Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | BAM | ET |
|---|---|---|
| Price | $44.27 | $20.49 |
| Change today | ▼ 2.20% | ▼ 0.02% |
| Market cap | $70.70B | $70.54B |
| Return, 3 months | -0.5% | +10.0% |
| Return, year to date | -11.1% | +30.9% |
| Return, 1 year | -19.8% | +26.5% |
| P/E (TTM) | 25.7 | 14.0 |
| P/B | 9.4 | 2.0 |
| P/E percentile vs own 5y | 31st | 86th |
| Dividend yield | 4.25% | 6.52% |
| Revenue growth (YoY, latest qtr) | +4.1% | +78.4% |
| Net profit growth (YoY) | +100.7% | +73.5% |
| Gross margin | 69.5% | 17.9% |
| Operating margin | 78.4% | 10.3% |
| Net margin | 58.2% | 4.7% |
| Return on equity | 35.1% | 14.4% |
| Analyst target vs. price | +30.8% | +21.4% |
| Analyst buy share | 50% | 86% |
| RSI (14) | 33 | 42 |
| 30-day volatility | 26.0% | 15.7% |
| Max drawdown, 1 year | -27.6% | -8.0% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.